Eightco Holdings (OCTO) said Monday it priced a private placement for 171.2 million shares at $1.46 each for gross proceeds of about $250 million. The company also said it received a $20 million investment from BitMine Immersion Technologies (BMNR).

Shares soared multifold as intraday trading volume surged to over 181.6 million from a daily average of about 1.13 million.

Rapport Therapeutics (RAPP) said Monday its phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.

Shares more than doubled as intraday trading volume soared to over 12.2 million from a daily average of roughly 179,000.

Beyond Air (XAIR) said Monday that the US Food and Drug Administration has granted orphan drug designation for its lead investigational therapy BA-101 to treat glioblastoma, which is an aggressive type of brain cancer.

Shares surged over 59% as intraday trading volume soared to more than 157.2 million from a daily average of about 278,000.

Price: 63.08, Change: +61.63, Percent Change: +4250.34